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Abstract
Background: Understanding how embryos specify asymmetric axes is a major focus of biology. While much has
been done to discover signaling pathways and transcription factors important for axis specification, comparatively
little is known about how epigenetic regulators are involved. Epigenetic regulators operate downstream of
signaling pathways and transcription factors to promote nuclear processes, most prominently transcription. To
discover novel functions for these complexes in axis establishment during early embryonic development, we
characterized phenotypes of a mouse knockout (KO) allele of the chromatin remodeling Ino80 ATPase.
Results: Ino80 KO embryos implant, but fail to develop beyond the egg cylinder stage. Ino80 KO embryonic stem
cells (ESCs) are viable and maintain alkaline phosphatase activity, which is suggestive of pluripotency, but they fail
to fully differentiate as either embryoid bodies or teratomas. Gene expression analysis of Ino80 KO early embryos by
in situ hybridization and embryoid bodies by RT-PCR shows elevated Bmp4 expression and reduced expression of
distal visceral endoderm (DVE) markers Cer1, Hex, and Lefty1. In culture, Bmp4 maintains stem cell pluripotency and
when overexpressed is a known negative regulator of DVE differentiation in the early embryo. Consistent with the
early embryo, we observed upregulated Bmp4 expression and down-regulated Cer1, Hex, and Lefty1 expression
when Ino80 KO ESCs are differentiated in a monolayer. Molecular studies in these same cells demonstrate that
Ino80 bound to the Bmp4 promoter regulates its chromatin structure, which correlates with enhanced SP1 binding.
These results in combination suggest that Ino80 directly regulates the chromatin structure of the Bmp4 promoter
with consequences to gene expression.
Conclusions: In contrast to Ino80 KO differentiated cells, our experiments show that undifferentiated Ino80 KO ESCs
are viable, but fail to differentiate in culture and in the early embryo. Ino80 KO ESCs and the early embryo up-
regulate Bmp4 expression and down-regulate the expression of DVE markers Cer1, Hex and Lefty1. Based on this
data, we propose a model where the Ino80 chromatin remodeling complex represses Bmp4 expression in the early
embryo, thus promoting DVE differentiation and successful proximal-distal axis establishment. These results are
significant because they show that epigenetic regulators have specific roles in establishing embryonic axes. By
further characterizing these complexes, we will deepen our understanding of how the mammalian embryo is
patterned by epigenetic regulators.
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Mammalian embryonic development is best understood
using the mouse model [1]. Fertilized eggs develop into a
blastocyst by embryonic day 3.5 (E3.5). At this stage, the
blastocyst is composed of both an inner cell mass (ICM),
which is fated to become the embryo, and an extraembry-
onic trophectoderm (TE). The blastocyst implants into
the uterus at E4.5, and during this time the embryo forms
the epiblast (EPI) and primitive endoderm (PrE). During
implantation the EPI rapidly proliferates and expands to
form an egg cylinder, which is composed of both embry-
onic ectoderm (EmE) and extraembryonic ectoderm (ExE)
covered by visceral endoderm (VE). During egg cylinder
expansion, the distal tip of the embryo differentiates into
the distal visceral endoderm (DVE), establishing a
proximal-distal (P-D) axis. During the transition from
E5.5 to E6.0, the DVE migrates up the anterior portion of
the embryo to create the anterior visceral endoderm
(AVE) where it has organizer activity through secreting
several inhibitors of the Tgfb and Wnt family ligands. The
secretion of these inhibitors constrains Tgfb and Wnt sig-
naling activity to the posterior portion of the embryo,
which promotes the differentiation of the primitive streak
and the anterior-posterior (A-P) axis.
Early mammalian development, and the establishment
of asymmetric axes (P-D and A-P axes), require coordi-
nated gene expression [2]. Gene expression is regulated
by both transcription factors and epigenetic regulators.
Both operate within chromatin, which is composed of
nucleosomes at its fundamental level [3, 4]. Essential
epigenetic regulators in eukaryotes are chromatin re-
modeling complexes. Chromatin remodeling complexes
are usually multi-subunit enzymes that slide or evict nu-
cleosomes, or exchange its histone subunits. These activ-
ities change chromatin structure by altering the position,
occupancy or composition of nucleosomes [5]. In turn,
changes in chromatin structure regulate access to the
underlying DNA, that in turn influences nuclear pro-
cesses like transcription.
Chromatin remodeling complexes are classified into
the SWI/SNF, ISWI, CHD or INO80 families based upon
the sequence homology of their ATPase subunit [5]. In
mammals, the INO80 family is composed of the Srcap,
p400, and Ino80 remodeling complexes. These com-
plexes are large, 12-15 subunit, complexes that are
unique among chromatin remodeling complexes because
they catalyze histone exchange reactions [6]. In addition
to histone exchange, Ino80 has significant nucleosome
sliding activity, suggesting that it can either alter nucleo-
some position or occupancy, or change nucleosome
composition in vivo. Presumably through these activities,
Ino80 regulates a variety of nuclear processes which in-
clude transcription, DNA repair, DNA replication, and
telomere structure [6].While much has been done to characterize the nuclear
functions of Ino80, little has been done to determine its
functions in metazoan development. In plants, INO80 is
essential for flowering and reproductive organ develop-
ment, possibly through functions in homologous recom-
bination and regulated transcription [7, 8]. In flies,
INO80 mutants are late embryonic lethal, deregulate
Hox gene expression, and manifest homeotic transfor-
mations [9]. In addition to Hox genes, INO80 regulates
ecdysone response genes, which are essential for pupal
development and molting [10]. Localization and nucleo-
some mapping studies in insect cells show that INO80 is
widely distributed throughout the genome and remodels
nucleosomes onto energetically unfavorable DNA se-
quences [11]. Similar to studies in plants and flies, mam-
malian Ino80 is also essential for development. Ex vivo
studies with Ino80 knockout (KO) or shRNA knock-
down (KD) pre-implantation embryos show that Ino80
maintains stem self-renewal by promoting the expres-
sion of pluripotency factors like Oct4 and stabilizing
DNA replication forks [12, 13]. In utero, Ino80 KO em-
bryos implant into the uterus but fail to develop to mid-
gestation, possibly due to roles for Ino80 in regulating
telomere structure or DNA damage repair [14]. Because
Ino80 is a well-documented regulator of gene expres-
sion, developmental defects could also result from ab-
normal gene expression [13].
Building on these earlier studies, we show that Ino80
KO embryos fail to specify a DVE and a P-D axis in
utero. Coincident with defects in the DVE, Ino80 KO
embryos aberrantly express Bmp4 in the EmE, a known
repressor of DVE specification [15]. Molecular studies
using differentiating ESC models show that Ino80 is spe-
cifically localized to the Bmp4 promoter, remodels its
chromatin structure, and regulates the binding of tran-
scription activators to its DNA sequence. These results
in combination suggest that Ino80 directly represses
Bmp4 expression in the EmE through its chromatin re-
modeling activity to promote DVE specification and P-D
axis establishment.
Results
Ino80 KO embryos fail to develop beyond the egg
cylinder stage
To discover the functions of Ino80 in mammalian devel-
opment, we created a conditional KO allele in mice
using Cre-loxp technology [16]. With this strategy, es-
sential exons are flanked by loxp sites that can be ex-
cised by tissue-specific Cre recombinase expression. The
targeted Floxed-Neo allele (Neo) is designed to delete
exons 2-4 of the Ino80 gene with Cre excision, deleting
the initiating ATG (Additional file 1a). To create both
the Ino80 Floxed allele (F) and the Ino80 deletion allele
(KO), we crossed mice carrying our targeted allele to
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nases. Successful recombination and germ line transmis-
sion of the Floxed and KO alleles were identified by
Southern blotting and PCR-based genotyping strategies
(Additional file 1b-d).
To determine if our targeted allele resulted in a loss of
Ino80 protein, we crossed a Tet inducible Cre expression
system (M2-rtTA and TetO-Cre alleles) into our Ino80
Floxed mice [17, 18]. Homozygous Ino80 Floxed (F/F)
mouse embryonic fibroblasts (MEFs), with or without
TetO-Cre, were isolated from mid-gestation E12.5 em-
bryos. As expected, the addition of doxycycline to TetO-
Cre, Ino80 F/F fibroblast cultures resulted in the conver-
sion of the Ino80 Floxed alleles to Ino80 KO alleles in
two days (Additional file 2a). Over this same time
course, Western blotting demonstrated a complete de-
pletion of the Ino80 protein by day 6 (Additional file
2b). Coincident with the depletion of the Ino80 protein,
we observed a loss of the exons 1-7 Ino80 transcript and
the appearance of two smaller Ino80 transcripts (KO-1
and KO-2) by RT-PCR (Additional file 2c, d). Cloning
and sequencing these smaller PCR products identified
aberrant exon 1-5 and exon 1-6 splice events for the
Ino80 transcript, with the deletion of exons 2-4 by Cre-
mediated recombination (Additional file 2d). In silico
translation from the first ATG of each aberrant splice
product results in an out of frame transcript and a ran-
dom protein product (Additional file 2e). These results
demonstrate that our Ino80 Floxed allele can be success-
fully excised by Cre recombinase, resulting in loss of the
Ino80 protein.
A previous publication showed that MEFs depleted of
Ino80 arrest the cell cycle and senesce [14]. To deter-
mine if depletion of Ino80 using our Ino80 Floxed allele
resulted in similar phenotypes, we counted the number
of viable fibroblasts over 12 days post-Cre expression by
doxycycline exposure. As described previously [14], we
observed that after doxycycline exposure Ino80 KO
MEFs stopped proliferating and senesced as identified by
an increased number of cells positive for endogenous b-
Gal activity, an indicator of senescence [19] (Fig. 1a-c).
Reproducing previous phenotypes of Ino80 KO MEFs
supports the conclusion that our Ino80 KO allele is a
null allele.
Phenotypes for Ino80 KO embryos are largely unchar-
acterized. To identify the functions of Ino80 in mamma-
lian development, we intercrossed mice heterozygous for
the Ino80 KO allele. Genotyping litters of mice from this
intercross identified no homozygous Ino80 KO mice,
demonstrating that Ino80 is essential for mouse viability
(Additional file 3). To stage the earliest point where
Ino80 is required for development, we genotyped litters
of embryos at mid-gestation (E13.5), gastrulation (E6.5),
and peri-implantation (E4.5). Results from theseexperiments showed that Ino80 KO homozygous em-
bryos were absent at E13.5, but present at the expected
Mendelian ratios at gastrulation (E6.5) and prior to im-
plantation (E4.5) (Additional file 3). These results dem-
onstrate that Ino80 is essential for mammalian
development post-gastrulation. A gross analysis of Ino80
KO embryos prior to (E5.5), during (E6.5), and post-
gastrulation (E7.5) reveled that Ino80 is important for
expansion of the egg cylinder during gastrulation
(Fig. 1d). Quantitation of embryo length showed that the
size of Ino80 KO embryos at E6.5 is similar to that ob-
served for Ino80 KO embryos at E5.5 (Fig. 1e). Embryo
reabsorption likely occurs after E7.5 because Ino80 KO
embryos after E7.5 begin to show a loss in structural in-
tegrity (data not shown).
Ino80 KO embryonic stem cells are viable but exhibit an
unstable pluripotent state
To characterize roles for Ino80 in the early embryo, we
isolated Ino80 KO embryonic stem cells (ESCs) from the
ICM of pre-implantation E3.5 Ino80 KO embryos. Col-
lection and genotyping pre-implantation E3.5-day blas-
tocysts from Ino80 KO heterozygous intercrosses
showed that Ino80 KO homozygous blastocysts look
morphologically similar to wild-type littermates by gross
inspection (Fig. 2a). These same isolated blastocysts suc-
cessfully attached and outgrew onto gelatinized plates in
media containing serum and leukemia inhibitory factor
(LIF). After seven days of outgrowth, we observed a
similar expansion of trophoblasts and the ICM between
wild-type and Ino80 KO blastocysts (Fig. 2a). From these
outgrowths, we successfully cloned Ino80 KO ESCs
under culture conditions that maintain ground state
pluripotency (media containing serum + 2i + LIF) [20,
21]. Western blotting showed that the Ino80 KO ESCs
do not have the Ino80 protein, further confirming that
our Ino80 KO allele is a null allele (Fig. 2b). Unlike
Ino80 KO MEFs, Ino80 KO ESCs proliferate and are not
apoptotic when maintained in culture under conditions
that promote ground state pluripotency (Additional file
4a, b). A microscopic analysis shows that Ino80 KO
ESCs did not form prototypical undifferentiated colonies
and exhibit slight cell scattering when maintained at
ground state pluripotency (Fig. 2c). Cell scattering is
more pronounced when the ESCs were passaged in a
media formulation that maintains a metastable pluripo-
tent state (serum + LIF) (Fig. 2c). The percentage of
colonies that maintain alkaline phosphatase (AP) stain-
ing was equivalent between wild-type and Ino80 KO
ESCs when maintained at ground state pluripotency
(Fig. 2d, e). However, Ino80 KO ESCs did not form ro-
bust AP positive colonies if the colony formation assay
was repeated when cells were maintained in a metastable
state (Fig. 2d, e). The ability to form AP positive colonies
Fig. 1 Ino80 is essential for embryonic fibroblast and early embryonic development. a Growth curve of conditional Ino80 KO MEF induced by
doxycycline treatment. 1.0 × 104 cells of control (Ino80 F/F) or Ino80 KO (Ino80 F/F, TetO-Cre) were seeded into media containing 10 μg/ml
doxycycline. Numbers of trypan blue negative cells were counted every two days over a 12-day period (N = 3 independent measurements per
group, representative of three biological replicates; * = t test p≤ 0.05). b Day-12 control and Ino80 KO cells from panel a were stained for
endogenous β-galactosidase activity at pH 6.0 to measure cellular senescence [19]. Black arrows designate β-galactosidase positive cells. c
Quantification of percentage β-galactosidase positive cells for day-12 control and Ino80 KO cells from panel (b) (N = 5 independent measurements
per group, representative of three biological replicates; * = t test: p ≤ 0.05). d Whole mount analysis of E5.5-, E6.5-, and E7.5-day wild-type (+/+)
and homozygous Ino80 KO (Ino80 KO/Ino80 KO) embryos harvested from +/Ino80 KO intercross breeding. e Length of E5.5- and E6.5-day
wild-type and Ino80 KO embryos were measured in whole mount using a calibrated microscope (N > 7 embryos per group; * = t test p≤ 0.05). KO
knockout, MEF mouse embryonic fibroblasts, E embryonic day
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are returned to ground state conditions (Fig. 2e). These
results demonstrate that Ino80 KO ESCs are viable, AP
positive, and morphologically show evidence of slight
cell scattering when compared to wild-type controls
when maintained at ground state pluripotency. However,
Ino80 KO ESCs lose AP staining and exhibit cell scatter-
ing when grown under conditions that maintain a meta-
stable pluripotent state.
To further characterize phenotypes of Ino80 KO ESCs
grown under differing culture conditions, we measuredtranscript levels of several markers of pluripotency, stem
cell differentiation, and lineage commitment. When
maintained at ground state pluripotency, Ino80 KO ESCs
have equivalent expression of pluripotency markers
Nanog, Oct4, Klf4, Sox2, and Essrb. Markers of ecto-
derm, mesoderm, and endoderm lineages were also ap-
proximately equivalent between wild-type and Ino80 KO
ESCs (Fig. 2f ). In contrast, we observed reduced pluripo-
tency marker expression (Nanog, Oct4, Klf4, and Essrb)
when Ino80 KO ESCs were maintained in the metastable
state for five days (Fig. 2g) [13]. These results are
Fig. 2 Ino80 KO ESCs are viable, but differentiate when maintained in a metastable pluripotent state. a Microscopic analysis of wild-type and Ino80
KO pre-implantation E3.5 blastocysts. Blastocysts were allowed to outgrow for seven days onto gelatinized plates in media containing serum +
LIF. Wild-type and Ino80 KO are at identical magnification. Red arrows designate ESC colony outgrowth. b Western analysis of Ino80 protein
expression in wild-type and Ino80 KO ESCs using a custom Ino80 antibody. Ponceau S was used as a loading control. c Microscope analysis of
wild-type and Ino80 KO ESCs grown in media containing serum + 2i + LIF or serum + LIF. Wild-type and Ino80 KO are at identical magnification.
d Alkaline phosphatase (AP) activity in wild-type and Ino80 KO ESCs after plating at clonal density and maintained in media containing serum +
2i + LIF or serum + LIF. Wild-type and Ino80 KO are at identical magnification. e Percent AP positive colonies quantified from panel d and after
Ino80 KO ESCs passaged in serum + LIF were recovered in serum + 2i + LIF. At least 50 colonies were quantified per group. f Quantitative RT-PCR
analysis of gene expression in wild-type and Ino80 KO ESCs maintained in serum + 2i + LIF. (N = 3 biological replicates) g Quantitative RT-PCR
analysis of gene expression in wild-type and Ino80 KO ESCs maintained in serum + LIF. (N = 3 biological replicates; * = t test p ≤ 0.05). KO knockout,
ESC embryonic stem cells, E embryonic day, LIF leukemia inhibitory factor,
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ground state pluripotency requiring Ino80.
Ino80 KO ESCs fail to differentiate using models of
mammalian development
To further characterize roles for Ino80 during mammalian
development, we differentiated Ino80 KO ESCs using the
teratoma model [22]. To create teratomas, both wild-type
and Ino80 KO ESCs maintained at ground state were in-
troduced into opposing flanks of NOD/SCID mice. Tera-
tomas were allowed to grow until control tumors were
approximately 1 cm in diameter. From five inoculations,
we harvested four wild-type tumors and two Ino80 KO tu-
mors. A histological analysis showed that control tumorsformed a wide range of differentiated tissues from each of
the three germ lines. Differentiated tissues include blood
islands, keratin pearls, and neural rosettes from the ecto-
derm lineage, both striated and smooth muscle from
mesoderm, and ciliated endoderm from the endoderm
lineage (Fig. 3a, b). In contrast to the well-differentiated
tissues observed in wild-type teratomas, we observed that
Ino80 KO teratomas are composed of undifferentiated
mesenchyme with a thin layer of epithelial cells on the
outer periphery (Fig. 3a, b).
In addition to forming teratomas, we utilized the em-
bryoid body ESC differentiation model [23]. To create
embryoid bodies, ESCs maintained at ground state were
dispersed in clumps and aggregated in serum containing
Fig. 3 Ino80 is essential for cell and tissue differentiation. a Low-magnification analysis of wild-type and Ino80 KO ESC differentiation as teratomas
in NOD/SCID mice. Scale bar = 500 μm. b High-magnification analysis of teratomas derived from wild-type ESCs showed evidence of (a’) blood
islands, (b’) striated muscle, (c’) ciliated endoderm, (d’) neural rosettes, (e’) keratin pearls, and (f ’) smooth muscle fields when sectioned and stained
with hematoxylin and eosin (H + E). Teratomas formed from Ino80 KO ESCs are composed of (g’) undifferentiated tissue surrounded by a (h’) thin
epithelial cell layer. Scale bar = 75 μm. c Analysis of 9-day embryoid bodies derived from wild-type and Ino80 KO ESCs. Frozen sections of
embryoid bodies derived from wild-type ESCs stained with H + E showed evidence of dark staining endoderm (Endoderm) and evidence of
internal cavitation (Cav) as previously described [24]. Embryoid bodies from Ino80 KO ESCs show evidence of disorganized endoderm and other
differentiated cell types. Scale bar = 200 μm. d Gene expression analysis of embryoid bodies derived from either wild-type or Ino80 KO ESCs
differentiated over nine days. Quantitative RT-PCR was used to measure the expression of a variety of differentiation markers, including Gata6,
Gata4, Foxa2, Hnf4a, Wnt3, Fgf8, T, Fgf5, Bmp4, and Nodal, and pluripotency markers, including Nanog, Klf4, Sox2 and Oct4. (Representative of
N = 3 biological replicates; * = t test p≤ 0.05). KO knockout, ESC embryonic stem cell
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vested at three-day intervals over the course of nine
days. Histological analysis of day-9 wild-type embryoid
bodies provided evidence of differentiated cell types in-
cluding a well-defined endoderm, and an organized mes-
enchyme with evidence of cavitation as previously
described [24] (Fig. 3c). In contrast, embryoid bodies de-
rived from Ino80 KO ESCs were not well organized and
lacked a continuous endoderm (Fig. 3c). We subse-
quently used RT-PCR to measure markers of pluripo-
tency and differentiated tissues in the embryoid bodies.
From these experiments, we observed that pluripotency
marker repression during embryoid body differentiationis largely Ino80-independent (Fig. 3d). In contrast to
pluripotency markers, we observed Ino80-dependent ex-
pression for several differentiation markers during em-
bryoid body differentiation. Ino80 KO embryoid bodies
showed enhanced expression of endoderm markers
Gata6 and Gata4 [25], and the stem cell maintenance
factor Bmp4 (Fig. 3d) [26]. The expression of these
markers could be linked since Bmp4 positively regulates
Gata4 and Gata6 expression [27]. In contrast to these
changes, Ino80 KO embryoid bodies showed reduced ex-
pression of the ectoderm marker Fgf5 [28], the endo-
derm marker Hnf4a [29], and mesoderm markers Fgf8
[30] and T [31] (Fig. 3d). Because the expression of these
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dependece of these same genes could contribute to a
post-implantation lethal phenotype.
Ino80 is expressed in the embryonic and extraembryonic
ectoderm of post-implantation embryos
In a first step towards understanding why Ino80 KO em-
bryos fail to develop beyond E6.5, we determined where
Ino80 is expressed during embryonic development and in
the adult. Towards this end, we performed in situ RNA
hybridization (ISH) using both sense and antisense probes
to the Ino80 transcript in E5.5- to E7.5-day embryos.
Whole mount ISH of E5.5 to E6.5 with sense and anti-
sense Ino80 probes showed widespread staining ofFig. 4 Ino80 is widely expressed in embryonic tissues and is essential for es
a Whole mount RNA in situ hybridization (ISH) of E5.5-, E6.5-, and E7.5-day
were photographed at identical magnification. Extraembryonic ectoderm (E
designated. b Increased magnification showing reduced antisense Ino80 rib
Embryos were photographed at identical magnification. c Frozen sections
riboprobe. Sagittal and cross sections through the ExE and EPI were obtain
hybridization of E6.5-, E5.5-, and E4.5-day embryos was performed with ant
include the ExE marker (Bmp4), EmE marker (Nodal), mesoderm marker (T),
Lefty1, and Hex1). Embryos were photographed at identical magnification. e
probes to the ExE marker Bmp4 (purple color) and the EmE marker Otx2 (m
Whole mount analysis of TUNEL positive cells in wild type and Ino80 KO E6
shown. Representative TUNEL positive cells are shown by black arrows. g Q
panel f (see methods section). N = 2 wild type (WT) or Ino80 KO embryos. E
endoderm, AVE anterior visceral endodermembryos with the antisense probe, but not the sense probe
(Fig. 4a). The most intense staining with the antisense
probe was observed in both the EmE and ExE, and com-
paratively less staining was observed in the VE (Fig. 4a, b).
The EmE contributes to all cell types of the embryo
proper, whereas the ExE contributes to the placenta and
umbilical cord [1]. To better visualize Ino80 ISH, we sec-
tioned E6.5-day embryos either sagittal or in cross section.
Inspection of these sections showed that staining with the
antisense Ino80 probe is highest in the ExE and EmE, with
less staining in the VE (Fig. 4c). Consistent with wide-
spread expression in the early embryo, Northern blotting
for Ino80 transcripts showed that it is expressed in all
adult tissues analyzed (Additional file 5). The combinationtablishing the proximal-distal axis of the post-implantation embryo.
embryos using either sense or antisense Ino80 riboprobes. All embryos
xE), embryonic ectoderm (EmE) and visceral endoderm (VE) are
oprobe staining in the visceral endoderm (VE) in E6.0-day embryos.
of E6.5-day embryos stained whole mount with antisense Ino80
ed for representative embryos. d Whole mount RNA in situ
isense riboprobes for markers of tissue differentiation. Markers used
EPI marker (Nanog), VE marker (Hnf4a), and PrE/DVE/AVE markers (Cer1,
Whole mount ISH of E5.5-day embryos was performed with antisense
agenta color). Embryos were photographed at identical magnification. f
.5-day embryos. A representative negative control (- TdT enzyme) is
uantitation of apoptosis as percentage of TUNEL positive cells from
embryonic day, EPI epiblast, PrE primitive endoderm, DVE distal visceral
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widely expressed in many tissues of post-implantation em-
bryo and the adult.
Ino80 KO embryos have a defective distal visceral
endoderm and fail to gastrulate
To better understand why Ino80 KO embryos fail to de-
velop, we used whole mount ISH to monitor marker ex-
pression for several essential cell types of the
gastrulating embryo. We focused our ISH on markers
previously analyzed from our studies of Ino80 KO em-
bryoid bodies (Fig. 3d). In the early embryo, gastrulation
occurs at E6.5 when the posterior of the embryo differ-
entiates into mesoderm and definitive endoderm [1]. Ini-
tial ISH experiments documented a lack of mesoderm
marker T expression in Ino80 KO embryos, suggesting
that they do not differentiate mesoderm and likely do
not gastrulate (Fig. 4d). Gastrulation requires the specifi-
cation of the AVE and is the first organizer of the mam-
malian embryo. The AVE secretes inhibitors to Tgfb and
Wnt ligands including Cer, and its expression at E6.5 is
a marker of the AVE [32]. At E6.5 Cer1 is not expressed
in the Ino80 KO embryo, suggesting that Ino80 is re-
quired for AVE establishment (Fig. 4d). In addition to
the AVE, signaling molecules that originate from the
ExE are essential for AVE establishment and gastrulation
[33]. One such molecule is the Tgfb superfamily member
Bmp4 [34]. ISH for Bmp4 transcripts showed that it is
weakly expressed in the ExE in Ino80 KO E6.5 embryos
(Fig. 4d). The results from these analyses demonstrate
that Ino80 KO embryos do not gastrulate and have de-
fects in specifying both the AVE and ExE.
To determine if defects in gastrulation result from de-
fects at earlier stages of development, we measured tis-
sue differentiation in Ino80 KO E5.5 embryos. From
these experiments, we observed that Bmp4, which is
normally expressed in the ExE [34], is abnormally
expressed in the EmE in Ino80 KO E5.5 embryos
(Fig. 4d). To further confirm EmE Bmp4 expression we
performed a double ISH using Bmp4 and the EmE
marker Otx2 [35]. From this experiment we show co-
localization of Bmp4 and Otx2 expression in Ino80 KO
E5.5-day embryos (Fig. 4e). To further monitor for de-
fects in the EmE, we next measured Nodal expression.
At E5.5 Nodal is expressed in the EmE where it pro-
motes proliferation of the epiblast and differentiates the
DVE [36]. In Ino80 KO E5.5 embryos, Nodal was nor-
mally expressed suggesting that the EmE is partially spe-
cified (Fig. 4d). Previous reports have shown that over
expression of Bmp4 in the early embryo inhibits DVE
differentiation [15]. To determine if Ino80 KO embryos
have a defective DVE, we measured the expression of
DVE markers Cer1, Hex1, and Lefty1 [37]. None of these
markers is expressed in E5.5 Ino80 KO embryos,suggesting that Ino80 KO embryos do not specify a DVE
(Fig. 4d). Defects in DVE specification could be due to a
general defect in the VE because we observed reduced
expression of the extraembryonic VE marker Hnf4a in
Ino80 KO embryos (Fig. 4d) [29]. These results demon-
strate that the DVE does not form in Ino80 KO E5.5 em-
bryos, which could result from expression of the
inhibitory molecule Bmp4 in the EmE and general de-
fects in the VE.
Both the VE and the DVE originate from the PrE,
which is specified during implantation at E4.5 [38]. To
determine if defects in the DVE result from defects in
the PrE, we stained Ino80 KO E4.5 embryos with the
PrE markers, Lefty1 and Hex1. From these experiments,
we observed equivalent expression of Lefty1 and Hex1,
suggesting that the PrE of Ino80 KO embryos are speci-
fied at E4.5 (Fig. 4c). In addition to the PrE, the E4.5 em-
bryo has an EPI that is the precursor to the E5.5 EmE
[38]. We next determined if the EPI is specified by stain-
ing for Nanog, a marker of the ICM and EPI. From these
experiments we observed equivalent expression of
Nanog in the EPI, suggesting that it is specified in Ino80
KO embryos (Fig. 4d).
We next stained E6.5-day embryos using TUNEL to
determine if defects in development are due to increased
apoptosis with Ino80 KO. From these experiments we
observed no increase of TUNEL positive cells between
wild-type and Ino80 KO embryos, suggesting that the ob-
served defects are not due to increased cell death (Fig. 4f,
g) and likely are due to reduced cell proliferation.
In combination, these expression studies demonstrate
that Ino80 KO embryos do not gastrulate. Defects in
mesoderm differentiation coincide with a lack of the
AVE and its organizer activity, and are not due to in-
creased cell death. The lack of an AVE at E6.5 is due to
the inability of Ino80 KO embryos to specify a DVE at
E5.5. The lack of a DVE coincides with the abnormal ex-
pression of Bmp4 in the EmE, a known negative regula-
tor of DVE differentiation [15]. Defects in the DVE are
not likely due to defects prior to E5.5 because both the
PrE and EPI appear to be normal in E4.5 Ino80 KO
embryos.
Ino80 represses Bmp4 expression during embryonic stem
cell differentiation
ISH experiments suggest that Ino80 represses Bmp4 ex-
pression during embryoid body differentiation and in the
EmE of early post-implantation embryos (Figs. 3d and
4d, e). These results suggest a model where Ino80
directly represses Bmp4 expression in the EmE. To ex-
plore if Ino80 directly represses Bmp4, we used an
in vitro model of early embryonic development. The dif-
ferentiation of ESCs in monolayer by withdrawal of 2i +
LIF in the presence of serum is a relevant model of early
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these conditions, they differentiate into EPI lineages in-
cluding EmE and mesoderm precursors [39]. Under
these conditions, we observe elevated expression of
Bmp4 in Ino80 KO ESCs (Fig. 5a). Elevated Bmp4 ex-
pression coincides with repression of DVE markers
Cer1, Hex, and Lefty1. Defects in DVE marker expres-
sion are not due to general defects in endoderm differ-
entiation because we observed equivalent expression of
endoderm markers Gata4 and Gata6 (Fig. 5a). In em-
bryonic tissue lineages Bmp4 is regulated by two up-
stream enhancers (Fig. 5b) [40]. Chromatin
immunoprecipitation (ChIP) experiments showed that
Ino80 is localized to the Bmp4 promoter, but not the en-
hancers, when ESCs are differentiated for six days in
serum containing media lacking 2i + LIF (Fig. 5c). Under
these same conditions, we next used formaldehyde
assisted isolation of regulatory elements (FAIRE) to de-
tect differences in open chromatin at the Bmp4 pro-
moter in Ino80 KO ESCs. From these studies, we
detected increased open chromatin ~1.5 Kb upstream of
the Bmp4 transcription start site in Ino80 KO ESCs
(Fig. 5d, e). These changes in chromatin structure at
~1.5 Kb upstream of Bmp4 correlated with increased
H3K4me3 and SP1 occupancy (Fig. 5f, g). H3K4me3 is a
well characterized mark of active promoters [41], and
SP1 is a transcription factor known to activate Bmp4 ex-
pression [42]. In combination, these experiments suggest
that Bmp4 is a direct target of Ino80 chromatin remod-
eling activity with consequences to SP1 binding and
Bmp4 expression. From these studies, we present a
model where Ino80 normally represses Bmp4 expression
in the EmE. When Ino80 is deleted, Bmp4 expression in-
creases, DVE differentiation is repressed, and embryonic
development is stopped (Fig. 5h).Discussion
In the last few decades it has been discovered that chro-
matin remodeling complexes are essential for many as-
pects of mammalian development [43, 44]. Several
chromatin remodeling complexes are essential for pre-
implantation development including SWI/SNF (Brg1
KO) [45], NURD [46], and TIP60/p400 [47] complexes.
In contrast, several other complexes including NURF
(Bptf KO) [48] and CHD7 [49] have post-implantation
phenotypes, suggesting that they regulate specific devel-
opmental pathways. Similarly, we showed that Ino80 KO
embryos implant, but fail to develop beyond the egg cy-
linder stage. These findings contrast with the cell essen-
tial functions for Ino80 in differentiated MEFs, where it
regulates telomere structures and DNA replication [12,
14]. The viability of Ino80 KO ESCs, but not MEFs,
could be due to differences in telomere structure andDNA replication, which are known to occur between the
cell types [50, 51].
To understand better how Ino80 regulates embryonic
development, we derived Ino80 KO ESCs from pre-
implantation embryos. We maintained Ino80 KO ESC
under growth conditions that promote either ground
state (serum + 2i + LIF) or metastable pluripotency
(serum + LIF). Previous studies have shown that these
culture conditions simulate growth conditions of the
E3.5 blastocyst ICM (ground state) or E4.5 EPI and PrE
(metastable state) [21]. Ino80 KO ESCs remain undiffer-
entiated at ground state pluripotency, but begin to show
signs of differentiation in the metastable state, including
loss of robust AP staining, and down-regulation of pluri-
potency markers Nanog, Oct4, Klf4, and Esrrb. These re-
sults support a model where Ino80 is not required to
maintain the pluripotent E3.5 blastocyst ICM in utero,
but rather has essential functions in regulating cellular
differentiation of the E4.5 peri-implantation embryo.
Our conclusions deviate slightly from previous studies
which document that Ino80 is required to maintain ESC
pluripotency and pre-implantation development [13].
Differences in methods used to achieve loss of function
could explain these contrasting reports. The use of a
siRNA KD approach could deplete maternal Ino80 tran-
scripts, thus revealing pre-implantation phenotypes [13].
Conversely, a genetic KO approach would leave maternal
Ino80 transcripts intact, mask any pre-implantation phe-
notypes, and allow the embryo to progress to post-
implantation development (this study and [12, 14]).
In addition, the discrepancy could arise because Ino80
is required for Oct4, Nanog, and Sox2 expression in the
metastable state (serum + LIF) [13], but not the ground
state (2i + LIF) [this study]. The ability of 2i + LIF to
mask the self-renewal defects of Ino80 KO ESC is not
unprecedented as it has also been reported for Mbd3
KO ESC [46, 52]. In the metastable state, FGF4/MAPK
signaling upregulates pro differentiation transcription
factors promoting differentiation [53, 54]. It is plausible
that depletion of Ino80, and the accompanying reduction
in Oct4 expression [13], could synergize with aberrantly
expressed pro differentiation factors to promote differ-
entiation in the metastable state. Alternatively, increased
H3K4me3 modified nucleosomes at the promoters of
pluripotency regulators in the ground state [21] could
recruit a redundant set of activating histone readers,
masking the Ino80 dependency of Oct4 expression.
To characterize functions for Ino80 during early em-
bryonic development we performed RNA ISH of several
differentiation markers in peri- and post-implantation
embryos. Our analysis documents that the DVE markers
Cer1, Hex, and Lefty1 are not expressed in Ino80 KO
E5.5 embryos. DVE establishment involves several Smad
signaling pathways including those activated by the
Fig. 5 Ino80 localizes to Bmp4 promoter and regulates its expression during embryonic stem cell differentiation. a Quantification of Bmp4, Hex,
Lefty1, Cer1, Gata6, and Gata4 expression by RT-qPCR during ESC differentiation in serum containing media without 2i + LIF in monolayer
(Representative of N = 3 biological replicates; * = t test p ≤ 0.05). b Cartoon showing the Bmp4 gene, location of upstream enhancers, and
immediate downstream convergent gene Gm15217 position of PCR amplicons used in chromatin immunoprecipitation (ChIP) experiments are
shown as black bars labeled 1-6. c Localization of Ino80 to regulatory elements of Bmp4 by chromatin immunoprecipitation (ChIP). ChIP was
performed with wild-type and Ino80 KO ESC after differentiation as a monolayer for six days in serum containing media lacking 2i + LIF. Position
of PCR amplicons are shown in panel a (Representative of N = 3 biological replicates; * = t test p≤ 0.05). d Cartoon showing the Bmp4 promoter
and the location of PCR amplicons used in FAIRE experiments are shown as black bars labeled 1-5. e Changes in chromatin structure ~1.5 Kb
upstream of Bmp4 in Ino80 KO ESC. FAIRE was performed with wild-type and Ino80 KO ESC after differentiation in serum containing media lacking
2i + LIF as a monolayer for six days. Position of PCR amplicons is shown in panel d (Representative of N = 3 biological replicates; * = t test
p≤ 0.05). f Increased H3K4me3 occupancy at Bmp4 in Ino80 KO ESC. ChIP was performed with wild-type and Ino80 KO ESC after differentiation as
a monolayer for six days in serum containing media lacking 2i + LIF. PCR amplicon 3 from panel b was used for ChIP (Representative of N = 3
biological replicates; * = t test p≤ 0.05). g Increased SP1 occupancy at Bmp4 in Ino80 KO ESC. ChIP was performed with wild-type and Ino80 KO
ESC after differentiation in serum containing media lacking 2i + LIF as a monolayer for six days. PCR amplicon 3 from panel b was used for ChIP
(Representative of N = 3 biological replicates; * = t test p ≤ 0.05). h Model for Ino80 function during proximal-distal axis establishment. In wild-type
embryos, Ino80 in part functions in the EmE to repress Bmp4 expression. Bmp4 repression in the EmE promotes DVE differentiation. In Ino80 KO
embryos, Bmp4 is abnormally expressed in the EmE, which inhibits DVE differentiation. A lack of a DVE prevents the AVE from forming, which
subsequently prevents gastrulation. ESC embryonic stem cell, LIF leukemia inhibitory factor, FAIRE formaldehyde assisted isolation of regulatory
elements, KO knockout, EmE embryonic ectoderm, DVE distal visceral endoderm, AVE anterior visceral endoderm
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Qiu et al. BMC Biology  (2016) 14:18 Page 11 of 15Nodal and Bmp4 ligands [15]. Nodal was the first dis-
covered ligand to promote the DVE [55], then later it
was discovered that Bmp4 signaling repressed the DVE
[15]. Bmp4 is normally expressed in the ExE, which is
proximally located from the distal tip of the embryo, and
future site of the DVE [34]. During egg cylinder expan-
sion (E4.5-E5.5), the ExE is rapidly moved away from the
distal tip of the embryo. During this period, the repres-
sive effects of Bmp4 on the distal tip of the embryo sub-
side due to the increased distance between the ExE and
distal tip during egg cylinder expansion [34], and activat-
ing Nodal signals become dominant due to increased
Nodal expression in the EmE [55, 56]. In this model, the
combined loss of Bmp4 signaling and increased Nodal
signaling to the distal VE, establishes the DVE [15].
From our studies, we observed that Nodal is Ino80-
independent during embryoid body differentiation and
embryonic development. In contrast to Nodal, we ob-
serve that Bmp4 is upregulated during embryoid body
differentiation and in the E5.5 EmE. The abnormal ex-
pression of Bmp4 in the EmE could result in down regu-
lation of DVE markers [15]. Alternatively, defects in the
DVE could result from general defects in the VE as sup-
ported by reduced Hnf4a expression with Ino80 KO, or
due to reduction in epiblast proliferation. Ino80 repres-
sion of Bmp4 expression in the EmE could be direct be-
cause it localizes to, regulates chromatin structure and
transcription factor occupancy at, the Bmp4 promoter
during ESC differentiation. In addition to these factors,
we observed reduced Bmp4 expression in the ExE, sug-
gesting that Ino80 could also be an activator of Bmp4 in
extraembryonic tissues. These activities could also be
direct, and the study of Bmp4 expression in differentiat-
ing Ino80 KO trophoblast stem cells could test this hy-
pothesis [57].Conclusions
From the data presented in this manuscript, we show
that Ino80 is required to pattern the early embryo. Using
several models of development, we showed that Ino80
KO embryos upregulate Bmp4 expression, and when
measurable, we observed a coincident repression of the
DVE markers Cer1, Hex, and Lefty1. Because Bmp4 re-
presses the DVE, we propose that the lack of a DVE in
Ino80 KO embryos is in part due to elevated Bmp4 ex-
pression in the EmE. Ino80 functions in regulating
Bmp4 expression are likely direct because we observed
specific Ino80 localization to its promoter in differentiat-
ing ESCs. We also observed evidence that Ino80 re-
models chromatin and regulates SP1 binding at the
Bmp4 promoter under these same conditions. These re-
sults support a model where Ino80 directly represses
Bmp4 expression in the EmE, and its repression isessential for DVE establishment and ultimately a func-
tional P-D axis (Fig. 5h).Methods
Gene targeting and animal husbandry
The RPC121 mouse PAC library (MRC, UK, London)
was screened using probe P2 internal to the Ino80 gene.
Probe hybridization was performed using 0.25 M sodium
phosphate pH 7.2, 1 mM EDTA, 7 % SDS at 65 °C over-
night. Blots were washed three times for 30 minutes
with 0.25XSSC, 0.1 % SDS at 65 °C. Five positive P1
clones were identified, and recombineering was used to
move the chr2: 119,464,212-119,447,795 (mm10 assem-
bly) DNA sequence from clone 386-C4 into DNDF-7.
Recombineering was subsequently used to insert an up-
stream loxp site and a downstream frt-Neo-frt-loxp se-
lection cassette.
Linearized Ino80 targeting vector was electroporated
into R1 ESC (129 Sv X 129Sv-CP F1) on feeder layers.
Neomycin resistant clones were isolated and screened
for successful Ino80 targeting using a BglI digest and
probe P2, BglI digest and probe P3, and an EcoRV digest
using probe P4. Primers used to amplify probes from
genomic DNA are available in Additional file 6. South-
ern blotting was performed as described for probe
hybridization. Ino80 was successfully targeted in 1 of
456 neomycin resistant clones. Germ line transmission
of Ino80 Floxed-Neo ESCs from two founder chimera
mice was confirmed by Southern blotting.
The Ino80 Floxed-Neo mice were crossed to Cre del-
eter (Jackson labs Cat#006054) and Flp deleter strains
(Jackson labs Cat#011065) to create Ino80 Floxed and
Ino80 KO alleles, respectively. Ino80 Floxed and Ino80
KO mice were then backcrossed to C57BL/6 J for five
generations and confirmed Cre and Flp negative by PCR
genotyping. Once backcrossed founder lines were estab-
lished, the Ino80 Floxed mice were cryopreserved at
Jackson Laboratory (Jackson labs Cat#027920). To create
Ino80 doxycycline inducible KO MEFs, the Ino80 Floxed
mice were crossed to TetO-Cre (Jackson Labs
Cat#006234) and subsequently rtTA (Jackson Labs
Cat#006965). MEFs were generated from an Ino80 F/F,
TetO-Cre hemizygous, rTTA homozygous X Ino80 F/F,
and rTTA homozygous cross. Genotypes of mice were
determined by PCR using the Ino80 genotyping protocol
or those provided by Jackson Labs for purchased alleles.
The Ino80 genotyping protocol includes primers P1, P2,
and P3 in a multiplex PCR reaction using recombinant
Taq polymerase with Termal Pol Buffer (NEB). PCR con-
ditions were as follows: 94 °C for three minutes for one
cycle, 94 °C for 30 sec, 54 °C for 60 sec, 72 °C for 45 sec
repeated for 40 cycles. Primer sequences are available as
Additional file 6.
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pathogen-free facility at Virginia Commonwealth Uni-
versity, Richmond VA, USA. Mice were maintained on a
12-hour light/dark cycle, and provided a low fat diet and
hypochlorinated water ad labium throughout the dur-
ation of the study. All experiments and animal proce-
dures were approved by the Animal Care and Use
Committee of Virginia Commonwealth University under
protocol AD10000372 and its modifications.
Cell line isolation and maintenance
To create Ino80 KO ESCs, we harvested and maintained
E2.5-day embryos in KSOM media until the blastocyst
stage. Expanded blastocysts were hatched using Tyrodes
solution (Sigma T1788) and allowed to attach and out-
grow on gelatinized plates for seven days in defined 2i +
LIF media without serum (Millipore Cat# SF016-100).
After outgrowth, the ICM was removed with a fine glass
pipette, dispersed with 0.25 % trypsin + EDTA, and ex-
panded in 2i + LIF + 15 % ESC grade serum (Life Tech-
nologies) media on gelatinized plates. Depending on the
experiment, ESC lines were also grown in 2i + LIF
growth media lacking serum (Millipore SF016-100), or a
serum + LIF formulation (15 % ESC grade FCS (Life
Technologies), DMEM, nonessential amino acids, 2 mM
glutamine, 10 μM β-mercaptoethanol, penicillin, and
streptomycin, 1000 U/ml LIF (Life Technologies)). ESC
lines were genotyped by PCR methods (see above) and
routinely maintained in serum + 2i + LIF containing
media on gelatinized plates. Ino80 KO at the protein
level was confirmed by Western blotting using a custom
rabbit polyclonal antibody and standard techniques. For
gene expression studies, cells were harvested from cul-
ture using Tri-Reagent (Sigma) and total RNA purified
according to the manufacture’s protocol. Quantitative
RT-PCR was performed as described below.
Primary MEFs were produced from E12.5-day embryos
using standard methods. MEFs were maintained in
DMEM containing 10 % FCS, 2 mM glutamine, 1 mM
nonessential amino acids, penicillin, and streptomycin.
All experiments were performed using early passage
(P0-1) fibroblasts. Ino80 deletion was achieved by adding
10 ng/ml doxycycline to the growth media for two days.
Following doxycycline exposure, the medium was re-
placed and MEFs were maintained at subconfluence
using standard tissue culture techniques. Efficiency of
Ino80 deletion was confirmed by PCR as described
above. Analysis of Ino80 transcripts was accomplished
by RT-PCR using Superscript II (Life Technologies)
followed by amplification using Phusion polymerase
(NEB). PCR fragments were cloned into pTOPO Blunt
Zero vector (Life Technologies) and sequenced.
To stain for β-galactosidase activity, MEFs were
washed in phosphate buffered saline (PBS) and thenfixed in 4 % buffered formaldehyde for five minutes.
Fixed cells were washed and then stained in 40 mM cit-
ric acid/sodium phosphate buffer, pH 6.0, containing
5 mM potassium ferrocyanide, 5 mM potassium ferri-
cyanide, 150 mM sodium chloride, and 2 mM magne-
sium chloride overnight with gentle rocking. Cells were
washed in PBS and blue cells counted with a
microscope.
Annexin V + 7AAD staining of ESC lines was performed
using AnnexinV-PE (BD Biosciences Cat#556421) using
the protocol provided by BD Biosciences.
To stain for AP activity, ESC colonies were first briefly
washed in PBS. Colonies were then fixed for five minutes
at room temperature in PBS containing 0.2 % glutaralde-
hyde, 0.02 % NP-40, and 0.01 % sodium DOC. Colonies
were then washed for ten minutes at room temperature in
100 mM Tris-HCl buffer, pH 9.5, containing 100 mM
NaCl and 10 mM MgCl2. Colonies were then stained in
BM purple AP substrate (Roche Cat# 11442074001) until
the desired level of staining was achieved. Cells were then
washed in PBS containing 0.1 % tween-20 and 2 mM
MgCl2. The plates were then air dried.
To determine doubling time cells were plated at 5 ×
105 cells per well in a 24-well plate and incubated for
the indicated time points, trypsinized, and counted using
a hemocytometer. Doubling time was calculated using
standard equations.
Teratoma and embryoid body production
To produce teratomas, 1 × 106 ESC were injected into
the flank of NOD/SCID mice (Jackson Labs Cat#
001303), after which the tumors were allowed to grow
for three weeks. The mice were then sacrificed, and the
tumors were removed and frozen in liquid nitrogen. Tu-
mors were sectioned in OCT medium using a cryostat,
fixed in 10 % neutral buffered formalin, stained with
hematoxylin and eosin, and visualized with light micros-
copy using standard techniques.
Embryoid bodies were created by transferring 10 × 106
ESC into 13 × 100 mm polypropylene culture tubes with
3 ml DMEM containing 15 % ESC grade FCS (Life Tech-
nologies), nonessential amino acids, 2 mM glutamine,
10 μM β-mercaptoethanol, penicillin and streptomycin
(2i + LIF withdrawal growth conditions). Upon harvest,
embryoid bodies were dispersed using Tri-Reagent
(Sigma) and total RNA was purified according to the
manufacture’s protocol. Total RNA was then processed
for quantitative RT-PCR as described below. Day 9 em-
bryoid bodies were fixed in 10 % neutral buffered forma-
lin overnight, washed in PBS, and then equilibrated in
OCT before freezing and sectioning with a cryostat. Sec-
tions were stained with hematoxylin and eosin and im-
aged using light microscopy according to standard
procedures.
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Embryos were dissected from timed pregnancies and
photographed or prepared for in situ hybridization as de-
scribed previously [48]. Alkaline phosphatase (AP)
coupled anti-DIG Fab fragments and BM Purple substrate
(Roche) were used to detect DIG labeled antisense probes
as previously described [48]. For co-localization staining,
DIG-Bmp4 and FITC-Otx2 antisense labeled probes were
detected by AP conjugated anti-DIG Fab and anti-FITC
Fab fragment, subsequently. The two probes were visual-
ized by two different AP substrates; the Bmp4 detection
used BM Purple (Roche) and Otx2 detection used INT/
BCIP (Roche) after inactivating the first AP activity (Otx2)
with 4 % formaldehyde for 30 min.
To measure apoptosis E6.5 embryos were fixed for
two hours at 4C, washed with PBST and kept in 100 % a
methanol until use. Embryos were treated with 5:1
methanol:30 % hydrogen peroxide for three hours. Then,
they were washed in a methanol and treated with 20 ug/
ul proteinase K for three minutes and fixed with 0.2 %
glutaraldehyde in 4 % paraformaldehyde for 20 minutes
at room temperature. Embryos were washed three times
with PBST and treated with sodium borohydride for
20 minutes. Embryos were then washed with TdT buffer
and apoptotic cells were detected by TUNEL staining
using a fluorescein in situ cell death detection kit
(Sigma). Apoptosis was calculated for each embryo by
averaging the percentage TUNEL+ cells (brown nuclei)
to all nuclei (DAPI staining) in three representative 50
um fields using microscopy.Formaldehyde Assisted Isolation of Regulatory Elements
(FAIRE)
FAIRE-qPCR was performed as described [58]. The
qRT-PCR cycle threshold (Ct) value from the Input and
FAIRE samples (control and Ino80 KO) were normalized
to signal from the reference region in each sample. Next,
the relative enrichment for site in the Bmp4 promoter in
comparison to the reference primer set was calculated
using the comparative ΔΔCt method. Primers used for
FAIRE are available as Additional file 6.Chromatin immunoprecipitation (ChIP)
ChIP was performed as described previously [48]. Anti-
bodies used include Ino80 (VCU23, custom rabbit poly-
clonal), SP1 (Santa Cruz Biotech # sc-59), pan histone
H3 (Abcam # ab1791), and H3K4me3 (Abcam #
ab1012). DNA quantification was accomplished using
SsoAdvanced universal SYBR Green supermix (Biorad)
according to the manufacturer’s established protocol.
Data collection was performed using a 7900HT Fast Real
Time PCR System (Applied Biosystems) and quantified
as % Input DNA for Ino80 or SP1, or as a ratio of %Input H3K4me3/pan H3. The primers used for ChIP are
available in Additional file 6.
Mouse Ino80 antibody VCU23 was raised in rabbits as
a GST fusion to aa792-892 of Genbank # AAH59235.1.
It was subsequently affinity purified by column chroma-
tography using 6 × His-aa792-892. Specificity to Ino80
was confirmed by Western blotting using Ino80 control
and KO ESC extracts. As a reference we observed identi-
cal results using the commercially available Ino80 anti-
body from ProteinTech (Cat# 18810-1-AP) (See
Additional file 7).
Gene expression assays
Quantitative RT-PCR was performed on cDNA libraries
converted using Superscript II (Life Technologies).
cDNA libraries were amplified using SsoAdvanced uni-
versal SYBR green supermix (Biorad) according to the
manufacturer’s established protocols. Primers used for
gene specific quantitative PCR were previously described
[48]. Data collection was performed using a 7900HT
Fast Real Time PCR System (Applied Biosystems) and
the ΔΔCt method was used to estimate transcript abun-
dance relative to the normalization control Gapdh.
Northern blotting was performed as previously de-
scribed [48]. A total of 1 ug of polyA+ RNA was re-
solved by 1 % formaldehyde agarose electrophoresis and
transferred to Hybond N+ (GE Health Sciences) using
the manufacturer’s suggested protocol. The Ino80 probe
was amplified from ESC cDNA library using Taq poly-
merase, sequenced to confirm identity and labeled with
P32 using random hexamer labeling. Detection was per-
formed by phosphoimager.
Statistics
Standard deviation was used to calculate error bars
throughout the study. P values were calculated using
two tailed T tests. Number of replicates are designated
in the figure legend.
Availability of supporting data
Data supporting the results of this article are available in
Additional file 8.
Additional files
Additional file 1: Figure S1. Targeting and genotyping strategy for
conditional and knockout Ino80 alleles. a Southern blotting strategy for
screening embryonic stem cell clones successfully integrating the Ino80
targeting vector. Probes used in the screen are positioned at the site of
hybridization, are designated in red, and are labeled P2, P3, and P4.
Restriction enzyme sites are designated above the genome sequence.
Loxp and Neo features of the targeting vector are shown in black. Exons
are shown as vertical lines and designated by number in sequential order
from 5′ to 3′. b Results of Southern blotting experiments to confirm
successful integration through Cre- or Flp-mediated recombination of the
Ino80 targeting vector. Wild-type targeted Ino80 Floxed-Neo (Neo), Ino80
Qiu et al. BMC Biology  (2016) 14:18 Page 14 of 15Floxed (Floxed) and Ino80 knockout (KO) alleles are shown. DNA fragment
sizes obtained from restriction enzyme digestion and Southern blotting
with P2, P3, and P4 probes are as expected from diagrams in panel a. c
Diagram describing PCR-based genotyping strategy. Ino80 alleles as
defined in panel a are shown in a cartoon format with exons and introns
not to scale. Position of the Loxp sites (red dots) and the Neo selectable
marker are shown relative to Ino80 exons 2-4, which are designated by
numbers. Positions of primers P1, P2, and P3 are shown as arrows
designating 5′-3′ orientation. PCR amplicons and their size are shown as
black bars above amplifying primers. d Results from the PCR genotyping
strategy using DNA from wild type and mice heterozygous for the Ino80
Floxed-Neo, Ino80 Floxed, and Ino80 KO alleles. (TIF 10353 kb)
Additional file 2: Figure S2. Molecular characterization of the Ino80 KO
allele. a Efficiency of Cre-mediated excision of Ino80 exons 2-4 from
control Ino80 Floxed/Floxed (Cre-Neg) and Ino80 Floxed/Floxed, TetO-Cre
(TetO-Cre) primary MEFs were monitored using the PCR genotyping
strategy. Cells were incubated with 10 μg/ml doxycycline for two days,
and then shifted to culture medium without doxycycline. DNA was taken
for analysis prior to the addition of doxycycline (Day 0), and at two, four
and ten days post-doxycycline addition. b Western blot analysis of Ino80
protein from total cell extracts prior to doxycycline addition (Day 0) and
six days after initial doxycycline treatment using a custom Ino80 antibody.
Ponceau S was used as a loading control. c Cartoon showing the position
of RT-PCR primers used for characterizing the Ino80 KO allele transcript.
Location of the forward primer in exon 1 and reverse primer in exon 7
are shown. The position of the loxp sites flanking exons 2-4 are shown as
black boxes. The position of the initiating ATG is shown in exon 2. d RT-
PCR results using primers shown in panel c on cDNAs converted from
total RNA harvested from control Ino80 Floxed/Floxed (Cre-Neg) and
Ino80 Floxed/Floxed, TetO-Cre (TetO-Cre) MEFs six days post-doxycycline
treatment. PCR products were gel purified, cloned and sequenced. Exon
composition of PCR fragments is shown. e Predicted reading frames for
the KO-1 and KO-2 transcripts initiating from the first available ATG.
(TIF 10038 kb)
Additional file 3: Genotyping results from intercross of heterozygous
Ino80 KO mice. Litters of mice or embryos at specified stages were
collected and genotyped using the PCR-based genotyping strategy.
Significant deviations from the expected genotype ratios were identified
using a Chi-Square test (**p < 0.01). (XLSX 10 kb)
Additional file 4: Figure S4. Ino80 is not essential for the growth and
viability of ESCs maintained in ground state pluripotency. a Growth curve
of wild-type and Ino80 KO ESCs. 1.0 × 104 cells were seeded onto gelati-
nized plates containing serum + 2i + LIF media. Numbers of trypan blue
negative cells were counted every day over a four-day period. (Doubling
Time, WT = 36 ± 4.5 hours, KO = 44 ± 4.2 hours; t test p ≤0.05, N = 3 bio-
logical replicates) b AnnexinV + 7AAD staining of wild-type and Ino80 KO
ESCs maintained in serum + 2i + LIF (N = 3 biological replicates).
(TIF 8494 kb)
Additional file 5: Figure S5. Ino80 is widely expressed in adult tissues.
Abundance of Ino80 transcripts in a variety of adult tissues was
determined by Northern blotting. Ethidium bromide stained rRNA serves
as a loading control. (TIF 1828 kb)
Additional file 6: Primers used in this Study. (XLSX 12 kb)
Additional file 7: Figure S7. Western blotting confirming custom Ino80
antibody. Western analysis of Ino80 protein expression in wild-type and
Ino80 KO ESCs using custom antibody VCU23 (a) and a commercially
available Ino80 antibody (ProteinTech Cat# 18810-1-AP) (b). In each case
Ponceau S was used as a loading control. (TIF 6874 kb)
Additional file 8: Supporting data. (XLSX 36 kb)Competing interests
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